Microchip Technology Incorporated (MCHP) SEC Filings & Earnings Calls
EquiReason read 14 Microchip Technology Incorporated SEC filings in the last 12 months. Latest: 8-K on 2026-08-19 — Additional shares authorized 12,000,000.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
- Market cap
- 40.2B
- P/E TTM
- 108.9
- Dividend yield
- 2.5%
- 52-week
- —
- Next earnings
- 5 Nov, in 12 days
Every filing, read
last 12 months · SECWhat happened, the numbers inside, guidance and risks. The original is one click away.
19 Aug 20268-K · 5.02, 5.07Additional shares authorized 12,000,000open
Figures in the filing · each found in the filing text
| Additional shares authorized · Q2-2026 | 12,000,000 |
Risks flagged
Potential dilution from increased share authorization for equity compensation.
“12,000,000 additional shares authorized under the 2004 Equity Incentive Plan.”
6 Aug 202610-QMicrochip reports sequential revenue growth across all segments and geographies, but continues to face capacity charges and macroeconomic uncertainty.earningsopen
Figures in the filing · each found in the filing text
| Unabsorbed capacity charges · Q1-2027 | $39M | |
| Outside foundry net sales percentage · Q1-2027 | 67.0% | |
| Distributor sales percentage · Q1-2027 | 52.0% |
Risks flagged
Tariff and trade policy risk
“New or increased tariffs imposed on raw materials, components, equipment, or other inputs used in our production processes could increase our manufacturing costs.” · word for word
China market and export control risk
“In 2025, China imposed and later expanded export restrictions and licensing requirements on certain rare earth elements and related magnets.” · word for word
Geopolitical instability in Middle East
“Geopolitical instability and conflicts in the Middle East, including military activity and hostilities involving Iran, create significant uncertainty for global markets, including energy and materials markets, and could adversely impact our operations and financial results.” · word for word
Customer inventory destocking risk
“The level of order cancellations or push-outs due to uncertain economic conditions or other factors.” · word for word
6 Aug 20268-K · 2.02Net sales $1.485B, up 38% YoY and 13.2% sequentially, above guidance high end; Non-GAAP EPS $0.76 vs guided $0.67-$0.71; book-to-bill well above 1; inventory days down to 175 from 185; guidance for Sep Q up 7-9% sequentially.earningsopen
Figures in the filing · each found in the filing text
| Net sales · Q1-FY2027 | $1.48B | +38% y/y |
| GAAP gross profit margin · Q1-FY2027 | 63.2% | |
| Non-GAAP gross profit margin · Q1-FY2027 | 63.8% | |
| GAAP operating income · Q1-FY2027 | $337M | |
| Non-GAAP operating income · Q1-FY2027 | $521M | |
| GAAP net income attributable to common stockholders · Q1-FY2027 | $202M | -535% y/y |
| Non-GAAP net income · Q1-FY2027 | $439M | +184% y/y |
| GAAP diluted EPS · Q1-FY2027 | $0.37 | -511% y/y |
| Non-GAAP diluted EPS · Q1-FY2027 | $0.76 | +181% y/y |
| Inventory days · Q1-FY2027 | 175 | -5% y/y |
Guidance
Q2 FY2027 net sales up sequentially 7% to 9% (midpoint ~$1.588B, YoY growth ~40.6%); GAAP EPS guided $0.28-$0.29 (actual $0.37 beat); Non-GAAP EPS guided $0.67-$0.71 (actual $0.76 beat); capital expenditures for September 2026 quarter and all of fiscal 2027 guided; adding capital equipment to selectively expand production capacity
Strong beat-and-raise quarter: revenue above guidance high end, EPS well above guided range, Sep Q guidance implies continued strong growth, improving margins from operational leverage, and selective capacity expansion capex
Risks flagged
Macroeconomic and geopolitical uncertainties could impact demand
“Any continued uncertainty, fluctuations or weakness in the U.S. and world economies (including China and Europe) due to changes in interest rates or high inflation, actions taken or which may be taken by the Trump administration or the U.S. Congress, monetary policy, political, geopolitical, trade or other issues in the U.S. or internationally (including the” · word for word
Tariff and trade policy risks
“The scope and level of tariffs; further changes in demand or market acceptance of our products and the products of our customers” · word for word
Inventory management and order volatility risks
“Changes or fluctuations in customer order patterns and seasonality; changes in utilization of our manufacturing capacity and our ability to effectively manage our production levels to meet any increases or decreases in market demand or any customer requests to reschedule or cancel orders” · word for word
24 Jul 20268-K · 5.02Reported a director or officer change (departure, election, appointment or pay arrangement)open
Risks flagged
Loss of COO; potential operational disruption and need for replacement.
“COO resigning; no successor announced.”
6 Jul 2026DEF 14AMicrochip filed its 2026 proxy statement, disclosing executive compensation changes in response to low say-on-pay vote, including increased performance-based equity for CEO.open
Figures in the filing · each found in the filing text
| Net Sales · FY2026 | $4.71B | |
| Non-GAAP Operating Income · FY2026 | $1.24B | |
| Non-GAAP Operating Margin · FY2026 | 26.3% | |
| Non-GAAP Diluted EPS · FY2026 | $1.64 | |
| GAAP Net Income · FY2026 | $119M | |
| Free Cash Flow Returned to Stockholders · FY2026 | $984M |
Risks flagged
Low Say-on-Pay Support
“At our 2025 Annual Meeting of Stockholders, 45.65% of the votes cast were in favor of our say-on-pay proposal.” · word for word
Cyclical Semiconductor Exposure
“the cyclical nature of the semiconductor industry” · word for word
21 May 202610-KNet sales $4.71B (+7% y/y); Gross profit margin 57.7; Operating income margin 10.4; Guidance: Capex expected ~$100M next 12 monthsopen
Figures in the filing · each found in the filing text
| Net sales · FY2026 | $4.71B | +7% y/y |
| Gross profit margin · FY2026 | 57.7% | |
| Operating income margin · FY2026 | 10.4% | |
| Net income · FY2026 | $230M | |
| Free cash flow · FY2026 | $871M | |
| Operating cash flow · FY2026 | $962M | +7% y/y |
| Capital expenditures · FY2026 | $91M | -28% y/y |
| Inventory days · FY2026 | 185 | -26% y/y |
| Distributor inventory days · FY2026 | 26 | -21% y/y |
| Total debt · FY2026 | $5.54B |
Guidance
Capex expected ~$100M next 12 months
Company expects continued revenue growth and inventory decline; capex guided lower.
Risks flagged
High leverage and debt refinancing risk
“Our financial condition and results of operations could be adversely impacted if we do not effectively manage or refinance our current or future debt.” · word for word
Malaysian tax dispute
“If the adjustment is upheld... it could result in income taxes and penalties up to MYR 1.9 billion (approximately $480.2 million).”
Geopolitical and tariff uncertainty
“There continues to be uncertainty regarding overall macroeconomic conditions, including increased geopolitical tensions, risk of a recession, and the effects of potential trade policies, including tariffs.” · word for word
7 May 20268-K · 2.02Net sales $1.31B (+35% y/y); Non-GAAP gross profit $808M; Non-GAAP operating income $401M; Guidance: June quarter net sales midpoint $1.456B, up 11% sequentially; non-GAAP EPS $0.67-$0.71 vs prior quarter $0.57earningsopen
Figures in the filing · each found in the filing text
| Net sales · Q4-2026 | $1.31B | +35% y/y |
| Non-GAAP gross profit · Q4-2026 | $808M | |
| Non-GAAP operating income · Q4-2026 | $401M | |
| Non-GAAP net income · Q4-2026 | $327M | |
| Non-GAAP EPS · Q4-2026 | $0.57 | |
| GAAP net income attributable to common stockholders · Q4-2026 | $116M | |
| GAAP EPS · Q4-2026 | $0.21 | |
| Net sales guidance midpoint (June quarter) · Q1-2027 | $1.46B | +35% y/y |
| Days of inventory · Q4-2026 | 185 | |
| Distributor inventory (days) · Q4-2026 | 26 |
Guidance
June quarter net sales midpoint $1.456B, up 11% sequentially; non-GAAP EPS $0.67-$0.71 vs prior quarter $0.57
Guidance raised significantly: revenue midpoint $1.456B (up 11% QoQ, 35.3% YoY); non-GAAP gross margin guided 62.25%-63.25% (expansion); non-GAAP EPS $0.67-$0.71 (up from $0.57). Demand accelerating, inventory normalizing, operating leverage improving.
Risks flagged
Restructuring charges and purchase accounting adjustments from previous acquisitions continue to impact GAAP results.
“GAAP results adversely impacted by amortization of acquired intangible assets associated with our previous acquisitions”
11 Feb 20268-K · 1.01, 2.03, 3.02, 8.01Microchip Technology issued $600M 0% convertible senior notes due 2030 in a private placement, increasing leverage and diluting shareholders via capped call transactions.open
Figures in the filing · each found in the filing text
| Convertible notes principal amount · 2026-02-11 | $600M |
Risks flagged
Potential dilution from convertible notes; increased leverage.
“0% Convertible Senior Notes due 2030; capped call transactions entered to mitigate dilution”
5 Feb 202610-QMicrochip reported sequential revenue improvement in the December 2025 quarter, but continued margin pressure from below-normal capacity utilization.earningsopen
Figures in the filing · each found in the filing text
| Net sales from outside wafer foundries · first nine month | 65.0% | |
| Unabsorbed capacity charges · first nine month | $154M | -11% y/y |
| Sales to distributors as percentage of net sales · first nine month | 47.0% |
Risks flagged
China trade and tariff risk
“On September 13, 2025, China's Ministry of Commerce initiated an antidumping investigation of imports into China of analog chips originating in the United States.” · word for word
Foundry dependency risk
“During the first nine months of fiscal 2026, approximately 65% of our net sales came from products that were produced at outside wafer foundries.” · word for word
Inventory and capacity utilization risk
“In the first nine months of fiscal 2026 and in fiscal 2025, we operated at below normal capacity levels resulting in unabsorbed capacity charges of $154.2 million and $173.0 million, respectively.” · word for word
5 Feb 20268-K · 2.02Net sales $1.19B (+16% y/y); Non-GAAP gross profit $717M; Non-GAAP operating income $338M; Guidance: Q4 FY2026 net sales midpoint $1.260B, +6.2% seq, +29.8% YoYearningsopen
Figures in the filing · each found in the filing text
| Net sales · Q3-2026 | $1.19B | +16% y/y |
| Non-GAAP gross profit · Q3-2026 | $717M | |
| Non-GAAP operating income · Q3-2026 | $338M | |
| Non-GAAP net income · Q3-2026 | $253M | |
| Non-GAAP EPS · Q3-2026 | $0.44 | |
| GAAP net income attributable to common stockholders · Q3-2026 | $35M | |
| GAAP EPS · Q3-2026 | $0.06 | |
| Net debt reduction · Q3-2026 | $26M |
Guidance
Q4 FY2026 net sales midpoint $1.260B, +6.2% seq, +29.8% YoY
Raised Q4 guidance above prior expectations; backlog and booking momentum strong; gross margin expected to expand further toward 65% target.
Risks flagged
Macroeconomic uncertainty could impact demand
“maintaining a disciplined approach given the evolving macro environment” · word for word
5 Jan 20268-K · 2.02Net sales $1.19B; Guidance: Net sales ~$1,185M vs original $1,109-1,149Mearningsopen
Figures in the filing · each found in the filing text
| net sales · Q3-2026 | $1.19B |
Guidance
Net sales ~$1,185M vs original $1,109-1,149M
Raised Q3 FY2026 net sales guidance; strong bookings and backlog; inventory correction progressing; factory ramp to reduce under-utilization charges.
Risks flagged
Macroeconomic and geopolitical risks remain; tariff and inflation uncertainty
“Cautionary statement lists risks including tariffs, interest rates, inflation, geopolitical conflicts.”
6 Nov 20258-K · 2.02Net sales $1.14B (-2% y/y); Non-GAAP operating income $277M; Non-GAAP net income $199M; Guidance: Q3 FY2026 net sales guidance $1.129B +/- $20Mearningsopen
Figures in the filing · each found in the filing text
| Net sales · Q2-2026 | $1.14B | -2% y/y |
| Non-GAAP operating income · Q2-2026 | $277M | |
| Non-GAAP net income · Q2-2026 | $199M | |
| Non-GAAP EPS · Q2-2026 | $0.35 | |
| GAAP net income attributable to common stockholders · Q2-2026 | $14M | -82% y/y |
| Book-to-bill ratio · Q2-2026 | $1.06 |
Guidance
Q3 FY2026 net sales guidance $1.129B +/- $20M
Q3 guidance slightly below Q2 actual but reflects typical seasonality; leading indicators (bookings, book-to-bill) positive.
Risks flagged
Broader market recovery developing more gradually than anticipated; December seasonality expected to be weak.
“the broader market recovery developing more gradually than anticipated; December is historically our seasonally weakest quarter” · word for word
6 Nov 202510-QMicrochip reported sequential revenue improvement in September 2025 quarter, indicating recovery from inventory correction, but with continued margin pressure from below-capacity operations.earningsopen
Figures in the filing · each found in the filing text
| Unabsorbed capacity charges · H1-2026 | $103M | |
| Outside foundry net sales percentage · H1-2026 | 65.0% | |
| China net sales percentage · H1-2026 | 18.0% | |
| Distributor net sales percentage · H1-2026 | 46.0% |
Risks flagged
China export controls and tariffs
“On September 13, 2025, China's Ministry of Commerce initiated an antidumping investigation of imports into China of analog chips originating in the United States.” · word for word
Rare earth supply constraint
“In April 2025, China imposed export restrictions on certain rare earth minerals.” · word for word
Customer supply chain disruption
“On September 30, 2025, the Dutch government took control of Nexperia... Various automotive and consumer electronics manufacturers may be adversely impacted by the Nexperia chip supply interruptions, resulting in a decrease in automotive and consumer electronics production, and a decrease in demand for our products by such customers.” · word for word
U.S. government shutdown
“As of the date of the filing of this report on Form 10-Q, the U.S. federal government has failed to complete their annual budget process or provide for a continuing resolution to fund government operations, resulting in a U.S. federal government shutdown.” · word for word
Microchip Technology Incorporated — questions
- What did Microchip Technology Incorporated file recently?
- 14 SEC filings in the last 12 months. Latest: 8-K on 2026-08-19 — Additional shares authorized 12,000,000
Every figure on this page comes from Microchip Technology Incorporated's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.